These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1358899)

  • 1. Evaluation of the role of electrostatic residues in human epidermal growth factor by site-directed mutagenesis and chemical modification.
    Campion SR; Tadaki DK; Niyogi SK
    J Cell Biochem; 1992 Sep; 50(1):35-42. PubMed ID: 1358899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EGF receptor binding of recombinant heregulinbeta1/EGF hybrids is blocked by heregulin residue glutamate 195.
    Chau BN; Nandagopal K; Niyogi SK; Campion SR
    Biochem Biophys Res Commun; 1996 Dec; 229(3):882-6. PubMed ID: 8954988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
    Campion SR; Matsunami RK; Engler DA; Niyogi SK
    Biochemistry; 1990 Oct; 29(42):9988-93. PubMed ID: 2271634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivation.
    Engler DA; Campion SR; Hauser MR; Cook JS; Niyogi SK
    J Biol Chem; 1992 Feb; 267(4):2274-81. PubMed ID: 1733935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-terminal charge affects the periplasmic accumulation of recombinant heregulin/EGF hybrids exported using the Escherichia coli alkaline phosphatase signal sequence.
    Campion SR; Elsasser E; Chung R
    Protein Expr Purif; 1997 Aug; 10(3):331-9. PubMed ID: 9268680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
    Geng JP; Cheng CH; Castellino FJ
    Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations within subdomain II of the extracellular region of epidermal growth factor receptor selectively alter TGF alpha binding.
    Harte MT; Gentry LE
    Arch Biochem Biophys; 1995 Oct; 322(2):378-89. PubMed ID: 7574711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase.
    Klingbeil CK; Gill GN
    Arch Biochem Biophys; 1999 Mar; 363(1):27-32. PubMed ID: 10049496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF).
    Shin SY; Yokoyama T; Takenouchi T; Munekata E
    J Pept Sci; 2003 Apr; 9(4):244-50. PubMed ID: 12725245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutants of charged residues in the active site of tyrosine hydroxylase.
    Daubner SC; Fitzpatrick PF
    Biochemistry; 1999 Apr; 38(14):4448-54. PubMed ID: 10194366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling.
    Donohue PJ; Sainz E; Akeson M; Kroog GS; Mantey SA; Battey JF; Jensen RT; Northup JK
    Biochemistry; 1999 Jul; 38(29):9366-72. PubMed ID: 10413511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.
    Holbrook MR; Slakey LL; Gross DJ
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):99-108. PubMed ID: 11062062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional importance of hydrophobicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding.
    Tadaki DK; Niyogi SK
    J Biol Chem; 1993 May; 268(14):10114-9. PubMed ID: 8486681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
    Vandenberg RJ; Rajendra S; French CR; Barry PH; Schofield PR
    Mol Pharmacol; 1993 Jul; 44(1):198-203. PubMed ID: 8393521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis of lysine382, the activator-binding site, of ADP-glucose pyrophosphorylase from Anabaena PCC 7120.
    Sheng J; Charng YY; Preiss J
    Biochemistry; 1996 Mar; 35(9):3115-21. PubMed ID: 8608152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
    Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
    Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
    Chanda PK; Minchin MC; Davis AR; Greenberg L; Reilly Y; McGregor WH; Bhat R; Lubeck MD; Mizutani S; Hung PP
    Mol Pharmacol; 1993 Apr; 43(4):516-20. PubMed ID: 8474430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of asparagine-32 in forming the receptor-binding epitope of human epidermal growth factor.
    Campion SR; Biamonti C; Montelione GT; Niyogi SK
    Protein Eng; 1993 Aug; 6(6):651-9. PubMed ID: 8234236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative effect of double-site mutations of human epidermal growth factor on receptor binding.
    Campion SR; Geck MK; Niyogi SK
    J Biol Chem; 1993 Jan; 268(3):1742-8. PubMed ID: 8380576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional importance of Leu15 of human epidermal growth factor in receptor binding and activation.
    Nandagopal K; Tadaki DK; Lamerdin JA; Serpersu EH; Niyogi SK
    Protein Eng; 1996 Sep; 9(9):781-8. PubMed ID: 8888144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.